EUROPEAN BIOTECH ACQUTN CORP's ticker is EBAC and the CUSIP is G3167F102. A total of 47 filers reported holding EUROPEAN BIOTECH ACQUTN CORP in Q2 2022. The put-call ratio across all filers is - and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2022 | $404,000 | +1.8% | 40,000 | 0.0% | 0.07% | +33.3% |
| Q3 2022 | $397,000 | +1.5% | 40,000 | 0.0% | 0.05% | +17.4% |
| Q2 2022 | $391,000 | +0.3% | 40,000 | 0.0% | 0.05% | +9.5% |
| Q1 2022 | $390,000 | +0.5% | 40,000 | 0.0% | 0.04% | +10.5% |
| Q4 2021 | $388,000 | +0.3% | 40,000 | 0.0% | 0.04% | -35.6% |
| Q3 2021 | $387,000 | +0.3% | 40,000 | 0.0% | 0.06% | -41.0% |
| Q2 2021 | $386,000 | – | 40,000 | – | 0.10% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| CONCOURSE FINANCIAL GROUP SECURITIES, INC. | 0 | $0 | 0.00% |